Products
Oncology APIs
| Product Name | Pharmacopoeia | Therapeutic Use | CAS No. |
|---|---|---|---|
| Hydroxy Urea / Hydroxycarbamide | IP/BP/USP/EP | Antimetabolites | 127-07-1 |
| Cyclophosphamide (Sterile / Non-Sterile) | IP/BP/USP/EP | Antineoplastic, Alkylating | 6055-19-2 |
| Letrozole | BP/USP | Aromatase inhibitor | 112809-51-5 |
| Gemcitabine HCL | BP/USP | Antimetabolite | 95058-81-4 |
| Gefitinib | IP/IHS/EP | Tyrosine Kinase inhibitors | 184475-35-2 |
| Tamoxifen Citrate | IP/BP/USP/EP | Antiestrogens | 54965-24-1 |
| Cytarabine | IP/BP/USP | Antimetabolite | 147-94-4 |
General APIs
| Product Name | Pharmacopoeia | Therapeutic Use | CAS No. |
|---|---|---|---|
| Camylofin Dihydrochloride | IHS | Antimuscarinic | 5892-41-1 |
| Modafinil | BP/USP | Stimulants | 68693-11-8 |
| Leflunomide | BP/EP/USP | Antirheumatic | 75706-12-6 |
| Promethazine HCL | IP/BP/USP | Antihistamines | 58-33-3 |
*IHS - In-house Standards
None of the products will be supplied to countries in which, it could be in conflict with the existing patent. However the responsibility lies with a buyer.